Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant — ParentsTREAT  

Microbial Colonization Clinical Trial

Official title: Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant to Promote Colonization Resistance to Staphylococcus Aureus

Status Recruiting

Clinical Trial Summary

This feasibility and safety pilot study looks to determine whether transferring a parents healthy, diverse nasal microbiota to the participant's infant(s) will create a healthy, diverse neonatal nasal microbiome.

Clinical Trial Description

The parent-to-child NMT study is a pilot study to test the feasibility of a parent-to-child nasal microbiome transplant. The investigators will test parent-to-neonate nasal microbiome transplantation as an intervention to reduce S. aureus acquisition in neonates. Neonates admitted to the Johns Hopkins Hospital neonatal intensive care unit (NICU) will be screened and parents will be approached for enrollment in the study. After consent and baseline screening of parents and neonates, eligible neonates will undergo a nasal microbiome transplant. This pilot study looks to determine whether transferring a parents healthy, diverse nasal microbiota to the infant(s) will create a healthy, diverse neonatal nasal microbiome. The investigators are planning an upcoming randomized controlled trial of this intervention and hope to establish feasibility during this pilot study. ;

Related Conditions & MeSH terms

• Communicable Diseases
• Infections
• Microbial Colonization
• Neonatal Infection
• Staphylococcus Aureus

• NCT number: NCT05695196
• Study type: Interventional
• Source: Johns Hopkins University
• Contact: Danielle Koontz
• Phone: 443-287-9040
• Email: dkoontz1@jhmi.edu
• Status: Recruiting
• Phase: Phase 1
• Start date: October 25, 2023
• Completion date: December 1, 2026